|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Reductions in 28-Day Mortality Following Hospital Admission for Upper Gastrointestinal Hemorrhage显示文摘 | Colin Crooks Tim Card Joe West | 2011 | Gastroenterology2011，，1： | 1 |
| 2 | A toolbox approach to adhesivedesign显示文摘 | Colin J Crook | 2006 | Reactive and Functional Polymers2006，66，1： | 1 |
| 3 | A toolbox approach to adhesive design 显示文摘 | COLIN J CROOK PATRICK A | 2006 | React Funct Polym2006，66，1： | 1 |
| 4 | Improved screening method for the detection of a range of nitroimidazoles in various matrices by optical biosensor显示文摘 | Colin S. Thompson Imelda M. Traynor Terence L. Fodey Steven R.H. Crooks | 2008 | Analytica Chimica Acta2008，，1： | 1 |
| 5 | Cyclin D1, E‐cadherin and beta‐catenin expression in FIGO Stage IA cervical squamous carcinoma: diagnostic value and evidence for epithelial–mesenchymal transition显示文摘 | Mei Hui E Koay Maxine Crook Colin J R Stewart | 2012 | Histopathology2012，，6： | 1 |
| 6 | 超常思维的力量 创新你的事业和生活显示文摘我们总以为自己看到的世界是真实的世界。事实上,所见即所想,而思维模式决定了我们的所思所想。改变思维模式,以超乎寻常的方式去看待世界,能够给我们带来天翻地覆的变化。 | Jerry Wind Colin Crook 周晓林(译) | 2006 | 全球商业经典2006，，10： | 0 |
| 7 | 趋吉避凶 变不可能为现实显示文摘事业和生活中的“战略转折点”是什么?你怎样在为时未晚时就意识到它们?当你到达这一点时,你是否有勇气放弃你现有的思维模式,拥抱新的想法。 | Jerry Wind Colin Crook 周晓林(译) | 2006 | 全球商业经典2006，，11： | 0 |
| 8 | Prognostic non-invasive biomarkers for all-cause mortality in nonalcoholic fatty liver disease:A systematic review and meta-analysis显示文摘BACKGROUND Non-alcoholic fatty liver disease(NAFLD)represents a growing public health concern,with patients having higher risk of morbidity and mortality.It has a considerably high prevalence in the general population,estimated 20%-40%in Europe,and is asymptomatic until late in the disease course.It is therefore important to identify and validate tools that predict hard outcomes such as mortality for use in clinical practice in risk-stratifying NAFLD patients.AIM To evaluate available evidence on the use of non-invasive test(s)as prognostic factors for mortality in NAFLD.METHODS We performed electronic searches of Medline and EMBASE(Ovid)until 7^(th)January 2021 of studies in NAFLD populations.Prognostic markers included serum biomarkers,non-invasive scoring systems,and non-invasive imaging.The population included all spectrums of disease severity,including NAFLD and non-alcoholic steatohepatitis(NASH).Outcomes included all-cause,and cardiovascular mortality.All non-invasive tests were synthesised in a narrative systematic review.Finally,we conducted a meta-analysis of non-invasive scoring systems for predicting all-cause and cardiovascular mortality,calculating pooled hazard ratios and 95%confidence(STATA 16.1).RESULTS Database searches identified 2850 studies-24 were included.16 studies reported non-invasive scoring systems,10 studies reported individual biomarkers,and 1 study reported imaging modalities.4 studies on non-invasive scoring systems(6324 participants)had data available for inclusion in the meta-analysis.The non-invasive scoring system that performed best at predicting all-cause mortality was NAFLD fibrosis score(NFS)[pHR 3.07(1.62-5.83)],followed by fibrosis-4 index[pHR 3.06(1.54-6.07)],BARD[pHR 2.87(1.27-6.46)],and AST to platelet ratio index[pHR 1.90(1.32-2.73)].NFS was also prognostic of cardiovascular-related mortality[pHR 3.09(1.78-5.34)].CONCLUSION This study reaffirms that non-invasive scoring systems,especially NFS,are reliable prognostic markers of all-cause mortality and cardiovascular mortality in NAFLD patients.These findings can inform clinical practice in risk stratifying NAFLD patients. | Nicole Cianci Mohsan Subhani Trevor Hill Amardeep Khanna Dong Zheng Abhishek Sheth Colin Crooks Guruprasad P Aithal | 2022 | World Journal of Hepatology2022，14，5： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员